Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed Phase Ib clinical trial of a new drug to treat inflammatory bowel disease (IBD) indicates that treatment may...